In this respect, selective AR modulators (SARM) are of interest (98) because it is conceivable that some may possess the requisite androgenic anti-growth and immunomodulatory activities in prostate cancer cells and favorable anabolic properties in other tissues. Here, AR is linked to prostate cancer.